SCHEMBL29390387

SCHEMBL29390387

CCOc1ccc(N=Nc2ccc(-c3ccc(N=Nc4c(O)ccc5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)c(C)c3)cc2C)cc1.[Na+].[Na+]

nearest known ligand 0.77

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 3/20 0.77
▸ P2RY4 known ✓ P51582 1/20 0.37
▸ P2RY6 known ✓ Q15077 1/20 0.37
▸ MAPK1 P28482 4/20 0.77
▸ ALDH1A1 P00352 3/20 0.77
▸ TDP1 Q9NUW8 2/20 0.77
▸ CYP3A4 P08684 2/20 0.77
▸ ALOX15 P16050 2/20 0.77
▸ ALOX12 P18054 2/20 0.77
▸ RECQL P46063 2/20 0.77
▸ HSD17B10 Q99714 2/20 0.77
▸ SMN1; SMN2 Q16637 1/20 0.77
▸ HIF1A Q16665 1/20 0.77
▸ APP P05067 1/20 0.58
▸ PTPN1 P18031 4/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ USP2 O75604 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ ALB P02768 1/20 0.42
▸ HSPD1 P10809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29438532 0.91 APP (0.66) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL18084213 0.88 ALDH1A1 (0.60) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL29678237 0.87 ALDH1A1 (0.59) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL29366607 0.87 THRB (1.00) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL18101484 0.81 CYP2C9 (0.61) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL29637843 0.79 THRB (0.85) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL29568770 0.78 THRB (0.86) MAPK1THRBALDH1A1TDP1CYP3A4
SCHEMBL185277 0.76 APP (0.98) MAPK1THRBALDH1A1TDP1CYP3A4
Orange G SCHEMBL81967 0.75 APP (1.00) MAPK1THRBALDH1A1TDP1CYP3A4
Orange G SCHEMBL29369740 0.75 APP (1.00) MAPK1THRBALDH1A1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article TOKUYAMA CORPORATION (JP) 2026-02-17 — — US disclosed
US-20260042309-A1 THERMAL-TRANSFER RECORDING MEDIUM, TRANSFERRED-MEDIUM FILM, AND METHOD FOR PRODUCING TRANSFERRED-MEDIUM FILM BROTHER KOGYO KABUSHIKI KAISHA (JP) 2026-02-12 — — US disclosed
US-20250355282-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-11-20 — — US disclosed
WO-2025233535-A1 METHOD FOR THE DETERMINATION OF CLEAVAGE SITES IN GENOMIC DNA CAUSED BY EXPOSURE TO A SITE DIRECTED NUCLEASE ETH Zürich (CH) 2025-11-13 — — WO disclosed
US-20250257162-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-08-14 — — US disclosed
US-12383504-B2 Acid resistant banding solution for two piece hard capsules CAPSUGEL BELGIUM NV (BE) 2025-08-12 — — US disclosed
US-12359081-B2 Ink, method for producing ink, and inkjet system RICOH COMPANY, LTD. (JP) 2025-07-15 — — US disclosed
EP-4566830-A1 FILM TO WHICH TRANSFER HAS BEEN COMPLETED AND PRODUCTION METHOD FOR FILM TO WHICH TRANSFER HAS BEEN COMPLETED BROTHER KOGYO KABUSHIKI KAISHA (JP) 2025-06-11 — — EP disclosed
EP-4566829-A1 THERMAL TRANSFER RECORDING MEDIUM, TRANSFER-COMPLETED FILM, AND PRODUCTION METHOD FOR TRANSFER-COMPLETED FILM General Co., Ltd. (JP) 2025-06-11 — — EP disclosed
EP-4566831-A1 THERMAL-TRANSFER RECORDING MEDIUM, TRANSFERRED-MEDIUM FILM, AND METHOD FOR PRODUCING TRANSFERRED-MEDIUM FILM BROTHER KOGYO KABUSHIKI KAISHA (JP) 2025-06-11 — — EP disclosed
CN-110337454-B Water-soluble composition, method for producing cured product thereof, and acylphosphinate 株式会社ADEKA 2022-04-12 — — CN disclosed
WO-2022072401-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI (US) 2022-04-07 — — WO disclosed
CN-109765652-B Composite retardation plate, optical laminate, and image display device 住友化学株式会社 2022-03-25 — — CN disclosed
CN-114185124-A Laminate and image display device 住友化学株式会社 2022-03-15 — — CN disclosed
CN-114174874-A Laminated body 住友化学株式会社 2022-03-11 — — CN disclosed
WO-2022050003-A1 OPTICAL LAMINATE, AND ELLIPSOIDALLY POLARIZING PLATE INCLUDING SAME 住友化学株式会社 2022-03-10 — — WO disclosed
CN-107664788-B Optical laminate 住友化学株式会社 2022-03-04 — — CN disclosed
CN-114144709-A Polarizing film and method for producing same 住友化学株式会社 2022-03-04 — — CN disclosed
CN-114127590-A Optical laminate and method for producing same 住友化学株式会社 2022-03-01 — — CN disclosed
CN-114072708-A Optical laminate 住友化学株式会社 2022-02-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article C5, SCO2, ZYX THRB 2158/4885P2RY4 1739/4885P2RY6 1602/4885
US-20260042309-A1 THERMAL-TRANSFER RECORDING MEDIUM, TRANSFERRED-MEDIUM FILM, AND METHOD FOR PRODUCING TRANSFERRED-MEDIUM FILM TRRAP, TRMT1L, TES THRB 1259/4885P2RY4 1715/4885P2RY6 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback